Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cardinal Health Says Despite Nonrenewal Of OptumRx Contracts, It Reiterates Its Pharmaceutical And Specialty Solutions Long-term Segment Profit CAGR Target Of 4%-6% And Its Consolidated Adjusted EPS CAGR Target Of 12%-14% For FY2024-FY2026

Author: Benzinga Newsdesk | April 22, 2024 06:51am

Posted In: CAH